NCT04000529 2025-09-30Phase Ib Study of TNO155 in Combination With Spartalizumab or Ribociclib in Selected MalignanciesNovartisPhase 1 Terminated122 enrolled
NCT01351103 2025-06-13A Study of LGK974 in Patients With Malignancies Dependent on Wnt LigandsNovartisPhase 1 Completed185 enrolled